ingenol mebutate (Picato®)

Reference No. 1392

Publication date:

31/07/2013

Last review date:

30/08/2016

Appraisal information

ingenol mebutate (Picato®) 150 micrograms/g gel
ingenol mebutate (Picato®) 500 micrograms/g gel

Company:	LEO Laboratories Ltd
BNF category:	Skin
NMG meeting date:	10/04/2013
AWMSG meeting date:	08/05/2013

Submission Type:	Full Submission
Status:	Recommended
Advice No:	1013
Ministerial ratification:	29/07/2013

Current Progress

Submission
received

NMG
meeting

AWMSG
meeting

Ministerial
Ratification

AWMSG advice

Ingenol mebutate (Picato®) is recommended as an option for use within NHS Wales for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (AK) in adults.

Final Appraisal Recommendation (FAR)

Download

ingenol mebutate (Picato) 1392 FAR

AWMSG Secretariat Appraisal Report (ASAR)

Download

ingenol mebutate (Picato) 1392 ASAR

Clinical Expert (CE) Summary

Download

ingenol mebutate (Picato) 1392 CE summary